Microbiome science to improve women’s health
9, 10 & 11 April 2024 | Copenhagen, Denmark
Presented by
Artwork by Ina Schuppe Koistinen
Committee
Acting Director, Institute for Genome Sciences
Professor of Microbiology and Immunology, University of Maryland School of Medicine
Ina Schuppe Koistinen
Jacques Ravel
Alliance Director Centre of Translational Microbiome Research
Karolinska Institutet
Kelle Moley
Vanessa K. Ridaura
Global VP of Clinical and Translational R&D, Reproductive Medicine and Maternal Health
Ferring Pharmaceuticals
Senior Program Officer - Microbiome Products
Bill & Melinda Gates Foundation
Niels Thun Andersen
Head of Life Science Team
Copenhagen Capacity
Director of Science - Future Labs
Chr. Hansen
Johan E.T. van Hylckama Vlieg
Adam Baker
CSO and Co-founder
Freya Biosciences
Women's health is an area of medicine that has historically been under-researched and under-funded. However, there has been growing recognition of the unmet need for research and treatments in this field. Microbiome research has shown promise in addressing some of these unmet needs. From the vaginal microbiome in reproductive health to the impact of menopause on the skin microbiome, the applications of microbiome science in women’s health are wide reaching and present an opportunity to develop novel therapeutic approaches and diagnostics.
Join us in Copenhagen for the first annual "Microbiomes in Women's Health Congress," where world-leading microbiome researchers, cutting-edge biotechs, and healthcare and pharmaceutical voices will unite to present their work on how the microbiome can be used to improve women's health.
The event will be split into chronological stages across a woman’s life spanning sessions on: exploring what is a typical vaginal microbiome, fertility, pregnancy, menopause, women-specific indications, and the development of therapeutics.